Background
In asthmatic lungs, elevated levels of thymic stromal lymphopoetin (TSLP) are linked to eosinophilic inflammation and disease severity [1]. TSLP is involved in initiating a TH2 inflammatory response, through activation of T cells, and recently, CD34+ hemopoietic progenitor cells [2,3]. However, the biological effects of epithelial-derived TSLP on human peripheral blood (PB) CD34+ progenitor eosinophil-basophil (Eo/B) lineage commitment have not been described. The aim of the current study is to examine the effects of primary bronchial epithelial cell-derived TSLP on CD34+ hemopoietic progenitor differentiation.
Methods
Primary bronchial epithelial cells (PBEC) grown in air-liquid interface were apically stimulated with media or varying doses of polyinosinic:polycytidylic acid (Poly I:C; 1, 10, 25, and 50g/mL) and cultured in the presence or absence of PB CD34+ cells in the basolateral compartment overnight. Supernatant was collected and analyzed for cytokine/chemokine secretion using Luminex assays. Overnight co-cultured PB CD34+ cells were (1) cultured in methylcellulose colony assays to assess for the mean numbers of Eo/B colony-forming units (CFU) (colonies were defined as ≥ 40 cells) after 14 d; or (2) assessed for TSLPR expression using flow cytometry.
Results
Preliminary data demonstrates that overnight stimulation of PBEC with poly I:C in the absence of PB CD34+ cells induced a dose-dependent release of IL-4, IL-5, IL-13, TNF eotaxin-1, and MCP-1; however, failed to secrete detectible levels of IL-1β and IFN-. Poly I:C at 10µg/mL enhanced TSLP and TARC secretion while at 50µg/mL, poly I:C enhanced IL-33 secretion from PBEC compared to unstimulated control. Furthermore, basal levels of IL-3, IL-6, IL-8, MDC, and RANTES were detected from rested PBEC, with no observable trend in secretion following poly I:C stimulation. Finally, PB CD34+ cells co-cultured overnight with poly I:C-stimulated PBEC have been cultured in methylcellulose colony assays and waiting for Eo/B CFU to be counted.
Conclusions
In conclusion, our co-culture system will allow for the establishment of epithelial-derived TSLP activity and its influence on CD34+ progenitor Eo/B differentiation. In the future, we would like to examine whether PBEC obtained from atopic vs. non-atopic individuals results in distinct progenitor response.
Acknowledgements
I would like to thank the AllerGen Network for the AllerGen Summer Studentship, and the members of the Denburg lab.
References
- Shikotra A, Choy DF, Ohri CM, Doran E, Butler C, Hargadon B. et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol. 2012;10:104–11. doi: 10.1016/j.jaci.2011.08.031. e1-9.)rinters. [DOI] [PubMed] [Google Scholar]
- Wang WL, Li HY, Zhang MS, Gao PS, He SH, Zheng T, Zhu Z, Zhou LF. Thymic Stromal Lymphopoietin: A Promising Therapeutic Target for Allergic Diseases. Int Arch Allergy Immunol. 2013;10:18–26. doi: 10.1159/000341665. [DOI] [PubMed] [Google Scholar]
- Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, Okubo K. Increased Expression and Role of Thymic Stromal Lymphopoietin in Nasal Polyposis. Allergy Asthma Immunol Res. 2011;10:186. doi: 10.4168/aair.2011.3.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]